The cost-effectiveness of specific allergen immunotherapy

June 13, 2011
| Reprints

Healthcare financing in the United States and elsewhere is likely to be in considerable flux for the foreseeable future.

ENT Journal provides full text articles to our registered members.
Please log in or sign up for a FREE membership to view the full content:

You may also like to: